Dicerna Pharmaceuticals
DRNA
#4014
Rank
ยฃ2.27 B
Marketcap
ยฃ29.19
Share price
0.00%
Change (1 day)
17,228.48%
Change (1 year)

Earnings for Dicerna Pharmaceuticals (DRNA)

Earnings in 2021 (TTM): -ยฃ85.79 Million

According to Dicerna Pharmaceuticals's latest financial reports the company's current earnings are ยฃ0.19 Billion. In 2020 the company made an earning of -ยฃ82.76 Million, an increase over its 2019 earnings that were of -ยฃ93.53 Million.

Earnings history for Dicerna Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-ยฃ85.79 Million3.66%
2020-ยฃ82.76 Million-11.52%
2019-ยฃ93.53 Million38.33%
2018-ยฃ67.62 Million46.14%
2017-ยฃ46.27 Million1.8%
2016-ยฃ45.45 Million-5.58%
2015-ยฃ48.13 Million32.01%
2014-ยฃ36.46 Million171.79%
2013-ยฃ13.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ5.32 B-6,022.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ8.43 B-9,493.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ5.13 B-5,814.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-ยฃ36.22 Million-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.93 B-1,138.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-ยฃ0.13 Billion 35.54%๐Ÿ‡บ๐Ÿ‡ธ USA